Scienceאברהם צנגן
Abraham Zangen
Abraham Zangen is an Israeli neuroscientist at Ben-Gurion University of the Negev who co-invented the H-coil used for deep transcranial magnetic stimulation (Deep TMS).
born 1969Co-inventing the H-coilDeep TMS researchCo-founding BrainsWayBrain reward system research

- Occupation
- neuroscientist, researcher
- Education
- Bar-Ilan University, Hebrew University of Jerusalem
Abraham Zangen was born in 1969 in Ramat Gan
Abraham Zangen was born in 1969 in Ramat Gan and grew up there. His parents were Holocaust survivors who came to Israel from the Netherlands in 1955. His mother, Dr. Miriam Zangen, was a physician who chaired the Israel Medical Association, and his father, Menachem Zangen, was a professor of chemistry.
He studied pharmacology at the Hebrew University for his first degree. He earned his PhD at Bar-Ilan University, together with the Weizmann Institute, in 1999. From 2000 to 2003 he was a postdoctoral fellow at the U.S. National Institutes of Health (NIH).
At the NIH he and physicist Yiftach Roth co-invented the H-coil, which allows deeper magnetic stimulation of the brain. In 2003 he co-founded the company BrainsWay to commercialize the technology and set up a lab at the Weizmann Institute. He became an associate professor there in 2010.
In 2012 he moved to Ben-Gurion University of the Negev, where he heads the brain stimulation and behavior lab and the psychobiology program. He became a full professor in 2015. His studies supported FDA clearances of Deep TMS for depression in 2013, OCD in 2018 and smoking cessation in 2020.
He lives in Jerusalem with his wife Rachel, a gynecologist. They have 6 children.
Milestones in Abraham Zangen's life
- 1969
Born in Ramat Gan.
- 1999
Earned his PhD from Bar-Ilan University.
- 2002
The NIH patented the first H-coil.
- 2003
Co-founded BrainsWay and opened a lab at the Weizmann Institute.
- 2010
Became an associate professor at the Weizmann Institute.
- 2012
Joined Ben-Gurion University of the Negev.
- 2013
The FDA cleared Deep TMS for treatment-resistant depression.
- 2015
Became a full professor.
- 2018
The FDA cleared Deep TMS for OCD.
- 2020
The FDA cleared Deep TMS for smoking cessation.
More people from the same world
Adi Kimchiborn 1947Research on programmed cell deathScience
Raz Yirmiyaborn 1956Immune activation and depression researchScience
Moshe Barborn 1964Research on mind-wanderingScience
Alon Chenborn 1970President of the Weizmann InstituteScience
Hermona Soreqborn 1947Acetylcholine signaling researchScience
Michal Schwartzborn 1950The concept of protective autoimmunityScience
Look up anyone else by name
Based on English Wikipedia, Abraham Zangen and Hebrew Wikipedia, אברהם צנגן, under CC BY-SA 4.0. The facts are Wikidata's.
Photograph: Abraham Zangen, CC BY-SA 3.0
Is this page about you or a family member? Ask for it to be taken off.